[1] Kotsakis P,Griffin M. Tissue transglutaminase in tumour progression: friend or foe? Amino Acids,2007,33:373-384 [2] Mehta K,Kumar A,Kim HI. Transglutaminase 2: a multi-tasking protein in the complex circuitry of inflammation and cancer. Biochem Pharmacol,2010,80:1921-1929 [3] Verma A,Mehta K. Tissue transglutaminase-mediated chemoresistance in cancer cells. Drug Resist Updat,2007,10:144-151 [4] Boddy JL,Fox SB,Han C,et al. The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a,HIF-2a,and the prolyl hydroxylases in human prostate cancer. Clin Cancer Res,2005,11:7658-7663. [5] Kuo TF,Tatsukawa H,Kojima S. New insights into the functions and localization of nuclear transglutaminase 2. FEBS J,2011,278:4756-4767. [6] Mangala LS,Fok JY,Zorrilla-Calancha IR,et al. Tissue transglutaminase expression promotes cell attachment,invasion and survival in breast cancer cells. Oncogene,2007,26:2459-2470. [7] Mann AP,Verma A,Sethi G,et al. Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway. Cancer Res,2006,66:8788-8795. [8] Dardik R,Inbal A. Complex formation between tissue transglutaminase Ⅱ(TGT-2) and vascular endothelial growth factor receptor 2(VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF. Exp Cell Res,2006,312:2973-2982. [9] Kim DS,Park KS,Jeong KC,et al. Glucosamine is an effective chemo-sensitizer via transglutaminase 2 inhibition. Cancer Lett,2009,273:243-249. [10] Yuan L,Behdad A,Siegel M,et al. Tissue transgluaminase 2 expression in meningiomas. J Neurooncol,2008,90:125-132. [11] Mian S,el Alaoui S,Lawry J,et al. The importance of the GTP-binding protein tissue transglutaminase in the regulation of cell cycle progression. FEBS Lett,1995,370:27-31.
2012, Vol. 21 
